Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 20, 2023
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
[ Thu, Jul 20th 2023
] - WOPRAI
Laura Chico Maintained (APLS) at Hold with Decreased Target to $40 on, Jul 20th, 2023
Laura Chico of Wedbush, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Decreased Target from $86 to $40 on, Jul 20th, 2023.
Laura has made no other calls on APLS in the last 4 months.
There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 1 agrees with Laura's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023
These are the ratings of the 5 analyists that currently disagree with Laura
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $100 on, Tuesday, July 18th, 2023
- Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $108 on, Friday, May 12th, 2023
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $110 on, Friday, May 5th, 2023
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $156 on, Friday, May 5th, 2023
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $141 on, Friday, April 14th, 2023
